| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +588K | 90.3% | $0.47 | +$277K |
| Sells | 1 | -63K | 9.7% | $0.35 | -$22.1K |
| Net | 0 | +525K | 80.7% | +$255K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sankesh Abbhi | Director | $3.86M | Dec 10, 2021 | ||
| Ralph Kern | COO and Chief Medical Officer | $396K | Mar 6, 2022 | ||
| Stacy Lindborg | Co-Chief Executive Officer | $322K | Mar 11, 2024 | ||
| Malcolm Taub | Director | $137K | Dec 15, 2021 | ||
| Uri Yablonka | EVP & Chief Business Officer, Director | $66.7K | Mar 11, 2024 | ||
| Ibrahim B. Dagher | Chief Medical Officer | $66.6K | -$22.1K | -24.9% | Jul 19, 2024 |
| Kirk Taylor | Chief Medical Officer | $62.1K | May 1, 2023 | ||
| Chaim Lebovits | President & CEO | $48.9K | +$277K | Sep 30, 2024 | |
| Anthony J. Polverino | Director | $46.1K | Feb 1, 2022 | ||
| Alla Patlis | Interim Chief Financial Officer & Controller | $34.3K | Mar 11, 2024 | ||
| June Sherie Almenoff | Director | $23.4K | Dec 15, 2021 | ||
| Nir Naor | Director | $21.3K | Jun 19, 2023 | ||
| Hartoun Hartounian | EVP, Chief Operating Officer | $15.5K | Jun 24, 2024 | ||
| Jacob A. Frenkel | Director | Apr 6, 2022 | |||
| Menghisteab Bairu | Director | Oct 28, 2021 | |||
| Irit Arbel | Director | Dec 15, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|